Chimp virus plays key role in malaria vaccine

A new blend of a genetically modified chimp adenovirus and a malaria gene is proving promising as a potential vaccine against malaria. The adenovirus is used to spur an immune response against malaria, a disease that claims a host of lives each year. By turning to a chimp adenovirus the Oxford University scientists say they can avoid the immunity built up in people against human adenoviruses. Governments set out in 2000 to halve the death rate from malaria by 2010, but there's little hope of reaching that goal without an effective vaccine. The Oxford team says that they believe that they could be within five years of a new vaccine.

- read the article from the BBC

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.